Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

False Claims, Off-Label Prescribing And Doctors, Part Two
Pharmalot
Thursday, September 5, 2013 - 8:45am
tags:
off-label, physicians, False Claims Act
Celgene says phase III study of pomalidomide combo met primary endpoint
Yahoo/Fly on the Wall
Thursday, September 5, 2013 - 8:26am
tags:
Celgene, pomalidomide, Multiple Myeloma
Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
Seeking Alpha
Thursday, September 5, 2013 - 8:24am
tags:
Novo Nordisk, diabetes
Amarin Regains Ahead Of Vital Q4 Catalysts
Seeking Alpha
Thursday, September 5, 2013 - 8:23am
tags:
Amarin, Vascepa
Sanofi will sell Pozen cardiovascular drugs in US
Yahoo/AP
Thursday, September 5, 2013 - 8:20am
tags:
Sanofi, Pozen, cardiovascular disease, PA8140, PA32540
Karo Bio Jumps After Reaching Milestone Payment: Stockholm Mover
Bloomberg
Thursday, September 5, 2013 - 8:17am
tags:
Karo Bio, Pfizer
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Yahoo
Thursday, September 5, 2013 - 8:15am
tags:
GSK, melanoma, Agenus
Three Ways To Understand GSK's China Scandal
Forbes
Thursday, September 5, 2013 - 8:13am
tags:
GSK, China
Patent ruling on Lilly's Alimta lung-cancer drug expected in 2014
Reuters
Wednesday, September 4, 2013 - 5:37pm
tags:
Eli Lilly, Alimta, lung cancer, patents
Japan's Otsuka to buy Astex Pharma for about $900 million
Reuters
Wednesday, September 4, 2013 - 5:33pm
tags:
Japan, M&A, Otsuka, Astex
Pursuing Alzheimer's, iPierian grabs $30M and spins off orphan drug biotech
Fierce Biotech
Wednesday, September 4, 2013 - 1:16pm
tags:
orphan drugs, iPierian, Alzheimer's disease, stem cells
Amgen With Onyx Pharmaceuticals: Long-Term Analysis
Seeking Alpha
Wednesday, September 4, 2013 - 1:15pm
tags:
Amgen, ONYX Pharmaceuticals, M&A
3 Biotech Products To Watch Over The Next Year
Seeking Alpha
Wednesday, September 4, 2013 - 1:14pm
tags:
Grafix, Osiris Therapeutics, Amarin, Vascepa, Abstral, Galena Biopharma
Human Hair Found in IV Solution Prompts Hospira Recall
Regulatory Focus
Wednesday, September 4, 2013 - 1:12pm
tags:
Humira, recalls, Aminosyn
Johnson & Johnson - 2 Strategies To Profit
Seeking Alpha
Wednesday, September 4, 2013 - 1:11pm
tags:
JNJ
Glaxo Hasn’t Escaped China Bribery Charges Quite Yet
Wall St. Cheat Sheet
Wednesday, September 4, 2013 - 12:56pm
tags:
GSK, China
How Is Pfizer Doing In The Anti-Infective Drugs Market?
Trefis
Wednesday, September 4, 2013 - 11:29am
tags:
Pfizer, anti-infectives, Prevnar 13
Medical device co C. R. Bard to buy peer Rochester Medical for $262 mln
Reuters
Wednesday, September 4, 2013 - 11:14am
tags:
CR Bard, M&A, Rochester Medical, devices
Judge makes rare move in Merck Fosamax litigation
Fierce Pharma
Wednesday, September 4, 2013 - 9:36am
tags:
Merck, Fosamax
ARIAD reaches 50% enrollment in Phase 3 EPIC trial
The Fly on the Wall
Wednesday, September 4, 2013 - 9:31am
tags:
Ariad Pharmaceuticals, clinical trials, chronic myeloid leukemia, Iclusig

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.